Cargando…
Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation
Chronic kidney disease (CKD) is associated with a higher risk of atrial fibrillation (AF). The mechanistic link between CKD and AF remains elusive. IL-1β, a main effector of NLR family pyrin domain–containing 3 (NLRP3) inflammasome activation, is a key modulator of conditions associated with inflamm...
Autores principales: | Song, Jia, Navarro-Garcia, Jose Alberto, Wu, Jiao, Saljic, Arnela, Abu-Taha, Issam, Li, Luge, Lahiri, Satadru K., Keefe, Joshua A., Aguilar-Sanchez, Yuriana, Moore, Oliver M., Yuan, Yue, Wang, Xiaolei, Kamler, Markus, Mitch, William E., Ruiz-Hurtado, Gema, Hu, Zhaoyong, Thomas, Sandhya S., Dobrev, Dobromir, Wehrens, Xander H.T., Li, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541185/ https://www.ncbi.nlm.nih.gov/pubmed/37581942 http://dx.doi.org/10.1172/JCI167517 |
Ejemplares similares
-
Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022) -
TGF-β1–induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?
por: Saljic, Arnela, et al.
Publicado: (2022) -
Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023) -
Characterization of atrial and ventricular remodeling in an improved minimally invasive mouse model of transverse aortic constriction
por: Navarro-Garcia, Jose Alberto, et al.
Publicado: (2023) -
Botulinum toxin for prevention of post-operative atrial fibrillation
por: Saljic, Arnela, et al.
Publicado: (2023)